文献速递认知障碍与痴呆帕金森病与运动障碍

脑脊液sAPPβ、YKL-40和神经丝轻链在额颞叶变性中的价值

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
PubMed 文献 · Neurology · 2017-06-07

该研究分析了159例FTLD相关综合征患者、72例AD患者和76例认知正常对照的脑脊液sAPPβ、YKL-40和NfL水平,发现FTLD患者sAPPβ较低且与额叶和扣带回皮质结构改变相关,sAPPβ/YKL-40和NfL/sAPPβ比值区分FTLD与对照的AUC分别为0.91和0.96,区分FTLD与AD的AUC分别为0.84和0.85。结论认为sAPPβ联合YKL-40或NfL可提高FTLD相关综合征诊断确定性。

要点

  • FTLD相关综合征患者脑脊液sAPPβ水平低于认知正常对照和AD患者
  • sAPPβ水平与额叶和扣带回皮质结构改变强相关
  • sAPPβ/YKL-40和NfL/sAPPβ比值有助于区分FTLD与对照及AD

核心结论

  • 脑脊液中sAPPβ联合YKL-40或NfL可能有助于提高临床实践中FTLD相关综合征诊断的确定性。

研究设计与样本

  • 研究纳入FTLD相关临床综合征患者159例,包括行为变异型额颞叶痴呆68例、非流利型原发性进行性失语23例、语义型原发性进行性失语19例、进行性核上性麻痹28例和皮质基底节综合征21例。
  • 研究还纳入AD患者72例和认知正常对照76例,比较组间脑脊液生物标志物水平及其与皮质厚度的相关性。

主要发现

  • FTLD相关综合征患者sAPPβ水平低于认知正常对照和AD患者。
  • sAPPβ水平与额叶和扣带回区域皮质结构改变强相关。
  • FTLD组和AD组的NfL和YKL-40水平均高于对照。
  • sAPPβ/YKL-40和NfL/sAPPβ比值区分FTLD与认知正常对照的AUC分别为0.91和0.96。
  • sAPPβ/YKL-40和NfL/sAPPβ比值区分FTLD与AD的AUC分别为0.84和0.85。

临床怎么用

  • 在临床实践中可考虑检测脑脊液sAPPβ、YKL-40和NfL,并计算sAPPβ/YKL-40或NfL/sAPPβ比值以辅助FTLD相关综合征的诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the clinical utility of 3 CSF biomarkers and their structural imaging correlates in a large cohort of patients with different dementia and parkinsonian syndromes within the spectrum of frontotemporal lobar degeneration (FTLD). METHODS: We analyzed 3 CSF biomarkers (YKL-40, soluble β fragment of amyloid precursor protein [sAPPβ], neurofilament light [NfL]) and core Alzheimer disease (AD) biomarkers (β-amyloid1-42, total tau, phosphorylated tau) in patients with FTLD-related clinical syndromes (n = 159): behavioral variant of frontotemporal dementia (n = 68), nonfluent (n = 23) and semantic (n = 19) variants of primary progressive aphasia, progressive supranuclear palsy (n = 28), and corticobasal syndrome (n = 21). We also included patients with AD (n = 72) and cognitively normal controls (CN; n = 76). We compared cross-sectional biomarker levels between groups, studied their correlation with cortical thickness, and evaluated their potential diagnostic utility. RESULTS: Patients with FTLD-related syndromes had lower levels of sAPPβ than CN and patients with AD. The levels of sAPPβ showed a strong correlation with cortical structural changes in frontal and cingulate areas. NfL and YKL-40 levels were high in both the FTLD and AD groups compared to controls. In the receiver operating characteristic analysis, the sAPPβ/YKL-40 and NfL/sAPPβ ratios had areas under the curve of 0.91 and 0.96, respectively, distinguishing patients with FTLD from CN, and of 0.84 and 0.85, distinguishing patients with FTLD from patients with AD. CONCLUSIONS: The combination of sAPPβ with YKL-40 and with NfL in CSF could be useful to increase the certainty of the diagnosis of FTLD-related syndromes in clinical practice. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CSF levels of sAPPβ, YKL-40, and NfL are useful to identify patients with FTLD-related syndromes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Alcolea D, Vilaplana E, Suárez-Calvet M, et al. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 2017. PMID: 28592456. doi:10.1212/WNL.0000000000004088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。